One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: The TRANSIT randomized trial in moderate-to-severe plaque psoriasis

Reich Kristian and Puig Lluís I. and Paul Carle and Kragballe Knud and Luger Thomas Anton and Lambert Jo L.W. and Chimenti Sergio and Girolomoni G and Nicolas Jean Francois and Rizova Elena and Brunori M and Mistry Sameer and Bergmans Paul and Barker Jonathan N.W.A and Kemény Lajos: One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: The TRANSIT randomized trial in moderate-to-severe plaque psoriasis.
British Journal of Dermatology, 170 (2). pp. 435-444. ISSN 0007-0963 (2014)

[thumbnail of 2833112_Reich_BJD_Ustekunimab.pdf] Text
2833112_Reich_BJD_Ustekunimab.pdf - Published Version
Restricted access: Registered users only

Download (438kB)
Item Type: Article
Szerzők száma: 114
Journal or Publication Title: British Journal of Dermatology
Date: 2014
Volume: 170
Number: 2
Page Range: pp. 435-444
ISSN: 0007-0963
Publisher: Wiley-Blackwell
Faculty/Unit: Faculty of Medicine
Department: Bőrgyógyászati és Allergológiai Klinika
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 2833112
DOI azonosító: https://doi.org/10.1111/bjd.12643
Date Deposited: 2015. Apr. 14. 15:55
Last Modified: 2018. Sep. 28. 09:48
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/5187
Web of Science® Times Cited: 32 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year